Multi- Versus Culprit-Vessel Percutaneous Coronary Intervention in Cardiogenic Shock.
暂无分享,去创建一个
W. O’Neill | Inder Singh | A. Goldsweig | T. McRae | Thomas A Lalonde | A. Bharadwaj | Robert F. Riley | A. Truesdell | K. Alaswad | S. Dixon | S. Marso | H. Aronow | S. Senter | N. Kapur | Rahul P. Sharma | A. Nsair | M. Alraies | S. Almany | M. Foster | D. Lasorda | Michael Ashbrook | Ayaz M. Rahman | N. Blank | A. Kaki | Omer Zuberi | Ivan D Hanson | Kirit Patel | P. M. Belford | Matheen A. Khuddus | S. Timmis | A. Khandelwal | James Park | John Baker | Lang Lin | Nainesh C. Patel | M. Basir | Behnam N Tehrani | A. Lemor | Michael Green | Brian C Kolski | A. Dupont | R. Askari | C. Caputo | M. Lim | Michael Schaeffer | A. Attallah | Ian Cawich | D. Wohns | W. O'Neill | S. Gorgis | Joseph L. Gelormini | J. Finley | Craig S. Smith | Raja Nazir | C. Wilkins | Scott Martin | Denes Korpas | T. Johnson | Michael Hacala | Theodore Schreiber | Simon Gorwara | Nalin Srivastava | Aditya Mehra | Osama Abdel-Hafez | I. Hanson | Robert Federici | Andrew M. Goldsweig | Amir Kaki | Brian C. Kolski | D. McAllister | Behnam N. Tehrani | Brian T. O’Neill | B. Tehrani | J. Todd | Yasir N Akhtar | Tijuan Overly | Timothy M. Larkin | Chandhiran Rangaswamy
[1] D. Burkhoff,et al. TCT-318 Hemodynamics of High-Risk Percutaneous Coronary Intervention With and Without Mechanical Circulatory Support: A Pilot Study With Pressure Volume Loop Analysis , 2019, Journal of the American College of Cardiology.
[2] Á. Avezum,et al. Complete Revascularization with Multivessel PCI for Myocardial Infarction. , 2019, The New England journal of medicine.
[3] Michael V. Green,et al. Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative , 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[4] B. Claessen,et al. Meta-Analysis Comparing Complete or Culprit Only Revascularization in Patients With Multivessel Disease Presenting With Cardiogenic Shock. , 2018, The American journal of cardiology.
[5] W. O’Neill,et al. Effects of Impella on Coronary Perfusion in Patients With Critical Coronary Artery Stenosis , 2018, Circulation. Cardiovascular interventions.
[6] M. Jeong,et al. Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock. , 2018, Journal of the American College of Cardiology.
[7] Marco Valgimigli,et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.
[8] Deepak L. Bhatt,et al. Culprit Vessel–Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment–Elevation Myocardial Infarction: A Collaborative Meta-Analysis , 2017, Circulation. Cardiovascular interventions.
[9] H. Thiele,et al. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock , 2017, The New England journal of medicine.
[10] F. Neumann,et al. Fractional Flow Reserve‐Guided Multivessel Angioplasty in Myocardial Infarction , 2017, The New England journal of medicine.
[11] B. Dawn,et al. Hemodynamic Support With a Microaxial Percutaneous Left Ventricular Assist Device (Impella) Protects Against Acute Kidney Injury in Patients Undergoing High-Risk Percutaneous Coronary Intervention , 2017, Circulation research.
[12] Harlan M Krumholz,et al. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infa , 2016, Journal of the American College of Cardiology.
[13] D. Kolte,et al. Trends in Incidence, Management, and Outcomes of Cardiogenic Shock Complicating ST‐Elevation Myocardial Infarction in the United States , 2014, Journal of the American Heart Association.
[14] C. Berry,et al. Randomized trial of preventive angioplasty in myocardial infarction. , 2013, The New England journal of medicine.
[15] Jane A. Linderbaum,et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[16] M. Hochadel,et al. Use and outcomes of multivessel percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock (from the EHS-PCI Registry). , 2012, The American journal of cardiology.
[17] Jeroen J. Bax,et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.
[18] B. Gersh,et al. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. , 2011, Journal of the American College of Cardiology.
[19] J. Gurwitz,et al. Recent magnitude of and temporal trends (1994-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: the second national registry of myocardial infarction. , 2001, American heart journal.